The effect of the selective cyclooxygenase-2 inhibitor rofecoxib on human colorectal cancer liver metastases (Q44569529)

4 December 2017

title

The effect of the selective cyclooxygenase-2 inhibitor rofecoxib on human colorectal cancer liver metastases (English)

1 reference

4 December 2017

1 reference

1 reference

4

Mark A Hull

0 references

Giles J. Toogood

object named as

Giles J Toogood

series ordinal

2

0 references

author name string

Stephen W Fenwick

series ordinal

1

1 reference

4 December 2017

J Peter A Lodge

series ordinal

3

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

4 December 2017

1 reference

4 December 2017

volume

125

1 reference

4 December 2017

issue

3

1 reference

4 December 2017

page(s)

716-729

1 reference

Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Review article: COX-2, prostanoids and colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

The role of cyclooxygenase-2 (COX-2) in two different morphological stages of intestinal polyps in APC(Delta474) knockout mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Cyclooxygenase-2 expression in colorectal cancer liver metastases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Inhibitory effect of a selective cyclooxygenase-2 inhibitor on liver metastasis of colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Selective cyclooxygenase-2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Host cyclooxygenase-2 modulates carcinoma growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

5-Fluorouracil induced Fas upregulation associated with apoptosis in liver metastases of colorectal cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Interstitial cell cyclooxygenase-2 expression is associated with increased angiogenesis in human sporadic colorectal adenomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Analysis of cyclooxygenase expression in human colorectal adenomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Indomethacin induces differential expression of beta-catenin, gamma-catenin and T-cell factor target genes in human colorectal cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Apoptosis occurs more frequently in metastatic foci than in primary lesions of human colorectal carcinomas: analysis by terminal-deoxynucleotidyl-transferase-mediated dUTP-biotin nick end labeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Rofecoxib, a COX-2 inhibitor, does not inhibit human gastric mucosal prostaglandin production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Is inhibition of cyclooxygenase required for the anti-tumorigenic effects of nonsteroidal, anti-inflammatory drugs (NSAIDs)? In vitro versus in vivo results and the relevance for the prevention and treatment of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Pharmacokinetics, COX-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Is a proliferation index of cancer cells a reliable prognostic factor after hepatectomy in patients with colorectal liver metastases?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Tumor angiogenesis in primary and metastatic colorectal cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Targeting angiogenic processes by combination rofecoxib and ionizing radiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Antiangiogenic effect of a highly selective cyclooxygenase-2 inhibitor on gastric ulcer healing in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

The contributions of cyclooxygenase-2 to tumor angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Suppression of angiogenesis and therapy of human colon cancer liver metastasis by systemic administration of interferon-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Therapeutic effect of TNP-470 on spontaneous liver metastasis of colon tumors in the rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Antiangiogenic therapy of transgenic mice impairs de novo tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Apoptosis signaling pathways mediated by cyclooxygenase-2 inhibitors in prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

National Cancer Institute workshop on chemopreventive properties of nonsteroidal anti-inflammatory drugs: role of COX-dependent and -independent mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barrett's esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

Drug inhibition of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901061-8

10.1016/S0016-5085(03)01061-8

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference